These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1152749)

  • 21. [The treatment of primary breast cancer. The late results].
    Letiagin VP
    Ter Arkh; 1992; 64(10):33-7. PubMed ID: 1485249
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro and in vivo effects of a monoclonal antibody-toxin conjugate for use in autologous bone marrow transplantation for patients with breast cancer.
    Coombes RC; Buckman R; Forrester JA; Shepherd V; O'Hare MJ; Vincent M; Powles TJ; Neville AM
    Cancer Res; 1986 Aug; 46(8):4217-20. PubMed ID: 3524802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of breast cancer: what are the trends in 1986?
    Ghys R
    CMAJ; 1986 Jul; 135(1):17-8. PubMed ID: 3719479
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effective treatment strategy in elderly breast cancer patients].
    Boér K
    Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Concomitant association of radiotherapy and chemotherapy in inflammatory breast cancer. Initial results of phase II trial].
    Campana F; Palangié T; Fourquet A; Pouillart P; Vilcoq JR
    Bull Cancer; 1991; 78(5):445-52. PubMed ID: 1878606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of hereditary breast cancer.
    Robson ME
    Semin Oncol; 2007 Oct; 34(5):384-91. PubMed ID: 17920892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer.
    Gutierrez-Delgado F; Holmberg LA; Hooper H; Appelbaum FR; Livingston RB; Maziarz RT; Weiden P; Rivkin S; Montgomery P; Kawahara K; Bensinger W
    Bone Marrow Transplant; 2000 Jul; 26(1):51-9. PubMed ID: 10918405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The 4th large meta-analysis of all trials of the treatment of operable breast cancer: increased survival after a longer follow-up].
    van Nes JG; Nortier WR; van de Velde CJ
    Ned Tijdschr Geneeskd; 2005 Sep; 149(36):1978-80. PubMed ID: 16171107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locoregional therapy improves survival for metastatic breast cancer patients? Benefit remains questionable!
    Chang DY; Lin CH; Lu YS
    J Clin Oncol; 2009 Nov; 27(31):e179; author reply e180. PubMed ID: 19738108
    [No Abstract]   [Full Text] [Related]  

  • 30. Adjuvant chemotherapy for breast cancer: an overview of NSABP findings.
    Fisher B; Redmond C; Elias EG; Evans J; Foster R; Jochimsen P; Lawrence W; Lerner H; LiCalzi N; Margolese R; Poisson R; Sachs S; Shibata H; Sutherland C; Wallack M
    Int Adv Surg Oncol; 1982; 5():65-90. PubMed ID: 7047408
    [No Abstract]   [Full Text] [Related]  

  • 31. Adjuvant treatment for breast cancer patients.
    Harmer V
    Nurs Times; 2000 Dec 7-13; 96(49):34-5. PubMed ID: 11965956
    [No Abstract]   [Full Text] [Related]  

  • 32. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation.
    Demirer T; Uysal VA; Ayli M; Genc Y; Ilhan O; Koc H; Dagli M; Arat M; Gunel N; Fen T; Dincer S; Ustael N; Yildiz M; Ustun T; Seyrek E; Ozet G; Muftuoglu O; Akan H
    Bone Marrow Transplant; 2003 May; 31(9):755-61. PubMed ID: 12732881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Are there limits to conservative treatment of breast cancer?].
    Clotteau JE; Bachelot F; Delouche G; Prémont M
    Chirurgie; 1994-1995; 120(6-7):349-53. PubMed ID: 7768124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.
    Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D
    Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of elderly patients with breast cancer].
    Paaschburg B; Pedersen A; Tuxen MK; Nielsen MM; Kroman N
    Ugeskr Laeger; 2008 Mar; 170(14):1133-8. PubMed ID: 18405474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melphalan (NSC-8806) in advanced breast cancer.
    Sears ME; Haut A; Eckles N
    Cancer Chemother Rep; 1966 Jul; 50(5):271-9. PubMed ID: 5936997
    [No Abstract]   [Full Text] [Related]  

  • 38. Preliminary clinical trial of DL-metasarcolysin (NSC-27381) for advanced carcinoma of the breast.
    Khung CL; Hall TC; Kelley RM; Grogan RH; Griffiths CT
    Cancer Chemother Rep; 1968 Apr; 52(3):413-6. PubMed ID: 5670724
    [No Abstract]   [Full Text] [Related]  

  • 39. Editorial: Treating breast cancer--true light or false dawn?
    Br Med J; 1976 Jul; 2(6030):263-4. PubMed ID: 953554
    [No Abstract]   [Full Text] [Related]  

  • 40. Breast cancer: have we lost our way?
    Lancet; 1993 Feb; 341(8841):343-4. PubMed ID: 8094117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.